Authorization for the company's board of directors to list CS MEDICA shares on the German Stock Exchange.

The Extraordinary General Meeting (EGM) resolved in accordance with the Board of Directors’ proposal to authorize the company's board of directors to list the company on one of the multilateral trading facilities (MTF) in Germany.

Authorization for the company's board of directors to list the company's subsidiary, CANNORDIC A/S, on the German Stock Exchange via an initial public offering (IPO) at a valuation of DKK 223.5 million (€30 million). Concurrent proposal to increase the number of shares of CANNORDIC A/S from the current 500 units of DKK 1,000 to 5,000,000 units of DKK 0.1, maintaining the same voting rights.

The EGM resolved, in accordance with the Board of Directors’ proposal, to approve the listing of the company's subsidiary, CANNORDIC A/S, on one of the multilateral trading facilities (MTF) in Germany via an initial public offering (IPO) at a valuation of DKK 223.5 million (€30 million). Concurrently, the EGM approved the proposal to increase the number of shares of CANNORDIC A/S from the current 500 shares with a nominal value of DKK 1,000 each to 5,000,000 shares with a nominal value of DKK 0.10 each, maintaining the same voting rights.

The total number of votes as of the date of this Statement is 12,322,635, whereof 71,8%, equal to 8,842,160, votes were represented at the EGM.

The resolutions were approved unanimously by all shareholders represented at the EGM.

For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/